Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

CTIC

CTI BioPharma (CTIC)

CTI BioPharma Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CTIC
DataHoraFonteTítuloCódigoCompanhia
06/07/202317:15Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:CTICCTI BioPharma Corporation
30/06/202307:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CTICCTI BioPharma Corporation
30/06/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CTICCTI BioPharma Corporation
28/06/202319:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTICCTI BioPharma Corporation
28/06/202319:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTICCTI BioPharma Corporation
28/06/202314:51Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CTICCTI BioPharma Corporation
26/06/202318:07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CTICCTI BioPharma Corporation
26/06/202317:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CTICCTI BioPharma Corporation
26/06/202311:35Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CTICCTI BioPharma Corporation
26/06/202310:21Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CTICCTI BioPharma Corporation
26/06/202309:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTICCTI BioPharma Corporation
26/06/202307:08Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CTICCTI BioPharma Corporation
24/06/202307:51PR Newswire (US)Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.NASDAQ:CTICCTI BioPharma Corporation
30/05/202317:35PR Newswire (US)CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of StockholdersNASDAQ:CTICCTI BioPharma Corporation
25/05/202308:01Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CTICCTI BioPharma Corporation
25/05/202307:46Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CTICCTI BioPharma Corporation
15/05/202317:29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTICCTI BioPharma Corporation
10/05/202315:03Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:CTICCTI BioPharma Corporation
10/05/202302:06PR Newswire (US)Sobi to Acquire CTI BioPharmaNASDAQ:CTICCTI BioPharma Corporation
04/05/202320:55PR Newswire (US)CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CTICCTI BioPharma Corporation
01/05/202317:46PR Newswire (US)CTI BioPharma To Report First Quarter 2023 Financial Results and Provide Corporate Update on Thursday, May 11, 2023NASDAQ:CTICCTI BioPharma Corporation
01/05/202308:03PR Newswire (US)CTI BioPharma Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CTICCTI BioPharma Corporation
28/04/202317:14Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CTICCTI BioPharma Corporation
28/04/202317:08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CTICCTI BioPharma Corporation
14/04/202309:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTICCTI BioPharma Corporation
12/04/202317:30PR Newswire (US)CTI BioPharma to Participate in Two Upcoming Investor Conferences in April 2023NASDAQ:CTICCTI BioPharma Corporation
06/03/202318:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CTICCTI BioPharma Corporation
06/03/202308:25PR Newswire (US)CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:CTICCTI BioPharma Corporation
01/03/202318:20PR Newswire (US)CTI BioPharma to Present at the 43rd Annual Cowen Health Care ConferenceNASDAQ:CTICCTI BioPharma Corporation
23/02/202309:03PR Newswire (US)CTI BioPharma To Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Monday, March 6, 2023NASDAQ:CTICCTI BioPharma Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:CTIC